Modular Medical Inc

Modular Medical Inc(MODD)股票分析

$3.420

-0.040 (-1.16%)收盘时

Loading chart…
High
3.670
Open
3.670
VWAP
3.43
Vol
680.26K
Mkt Cap
50.76M
Low
3.200
Amount
2.33M
EV/EBITDA, TTM
0.00

Modular Medical, Inc. is a medical device company. The Company is focused on the design, development, and commercialization of insulin pumps using technology to increase pump adoption in the diabetes marketplace. The Company's product seeks to serve both the type 1 and type 2 diabetes markets for those individuals requiring insulin. MODD1, its product, is a high-precision pump. MODD1's features include three parts - one reusable, two disposable - snap together to form the working system; one button interface; 90-day reusable, three-day disposable; removable system, slim profile, lighter weight, and no external controller required, no charging and no battery replacement. Its pump product comprises the pump, a disposable cartridge that holds the insulin reservoir, a baseplate that affixes the pump product to the user's body and the infusion set, which includes a cannula to infuse the insulin into the body.

AI analysis of Modular Medical Inc (MODD)

buy

Modular Medical Inc is a good buy right now due to its recent FDA clearance for a next-generation insulin patch pump, which has the potential to significantly increase market share. The current price is $3.46, and the stock has shown a 20-day change of +44.77%, indicating strong momentum. However, the company has reported consistent losses, with a net income of -7,790,000 USD in Q2 2026, which remains a risk for investors.

估值指标

The current forward P/E ratio for Modular Medical Inc (MODD) is 0.00, compared to its 5-year average forward P/E of -2.61.

Forward P/E

Strongly Overvalued
5Y Average P/E
-2.61
Current P/E
0.00
高估
-1.42
低估
-3.80

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
高估
0.00
低估
0.00

Forward P/S

Fair
5Y Average P/S
166.16
Current P/S
8.81
高估
457.42
低估
-125.10

事件时间线

2026-09-03 (ET)

08:30:00

Modular Medical Receives FDA Approval for Software Enhancements

2026-08-03 (ET)

08:30:00

Modular Medical Plans to Launch Tubeless Patch Pump in Five U.S. Markets in October 2026

2026-07-23 (ET)

08:30:00

Modular Medical Forms Pivot Innovation Council

2026-07-16 (ET)

08:30:00

Modular Medical Partners with IMO Health to Develop Diabetes Algorithm

2026-07-15 (ET)

08:30:00

Modular Medical Releases Positive Market Study Findings for Pivot Tubeless Patch Pump

资讯

MODD FAQ — answered by Alphio AI

Modular Medical, Inc. is a medical device company. The Company is focused on the design, development, and commercialization of insulin pumps using technology to increase pump adoption in the diabetes marketplace. The Company's product seeks to serve both the type 1 and type 2 diabetes markets for those individuals requiring insulin. MODD1, its product, is a high-precision pump. MODD1's features include three parts - one reusable, two disposable - snap together to form the working system; one button interface; 90-day reusable, three-day disposable; removable system, slim profile, lighter weight, and no external controller required, no charging and no battery replacement. Its pump product comprises the pump, a disposable cartridge that holds the insulin reservoir, a baseplate that affixes the pump product to the user's body and the infusion set, which includes a cannula to infuse the insulin into the body. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Modular Medical Inc is a good buy right now due to its recent FDA clearance for a next-generation insulin patch pump, which has the potential to significantly increase market share. The current price is $3.46, and the stock has shown a 20-day change of +44.77%, indicating strong momentum. However, the company has reported consistent losses, with a net income of -7,790,000 USD in Q2 2026, which remains a risk for investors.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始